23rd European Pharma and Biotech Project, Program and Portfolio Management Conference

2-Day Conference

Annual Project, Program, and Portfolio Management Conference in Pharma & Biotech with a focus on
New Ways of Working.

KEY TOPICS

You will hear experts talk about the current issues in this ever-evolving industry. The best practice case studies on how to build a portfolio function in an organization and how it evolves to mature portfolio management organisation.
What is the role of project management in different levels of maturity of PPM in different organizations?
How to prioritize projects, what methodologies to use for risk and decision analysis?

Considering market access.
Utilizing new ways of working including agile and digital tools.
Working with innovation, working with mature products, working in R&D projects, working in manufacturing. All topics we address, are addressed having our mission in our mind, bringing medicines to patients faster, sustainably for business needs.

EVENT FEATURES

LEARNING

Hear from 30 speakers across 28 case-studies, panel discussions, workshop sessions, and keynote presentations to find industry trends, benchmark your work, and learn new strategies

INNOVATION

Find real approaches to new ways of working. Learn about how key innovations (Machine Learning, Artificial Intelligence) are changing the ways we do Project & Portfolio and see how you could apply them.

NETWORKING

Explore the event's in-person networking features to meet industry peers, share challenges, discuss opportunities, and find new approaches.

2023 EVENT SPEAKERS

Karen Skinner

Chief Project and Portfolio Officer, LifeArc

Alan Crean

PPM Systems & Technologies Specialist, Cora Systems

Geert Deschamps

Head of Project Management Office, Operations and Communication Global Large Molecule Research, Sanofi

Daniela Braun

Head of Project Management DrugDevelopment & TechTransfer, Celonic Group

Sebastian Kirbach

Global Program Manager - Late Stage Development, Roche

Laura Jeanbart

Associate Director - Portfolio Management, Molecular Partners

Magali Musarella

Portfolio and Program Manager, Roche

Tania Nikolcheva

Global Development Leader Neuroscience - Late Stage/ PD, Roche Pharmaceuticals

Maris Prabhakaran

Global Manager Portfolio & Data Digitization, Johnson & Johnson

Gerrit Buurman

Director Project Management, Bachem

Martin Braun

Portfolio Manager, Roche

Ulrike Maria Grimm

Head of Project Management, Opterion Health AG

Richard Sonnenblick

Chief Data Scientist, Planview

Klemen Spaninger

Head of PMO Biotechnology, Gedeon Richter

Sabine Pfeffer

Senior Global Program Team Director, Novartis

Tram Finn

PMO Director, Terumo Europe

Thomas Halliwell

Senior Vice President & Head of Operations, Ariceum Therapeutics

Rainer Mussmann

Director, Novartis

Antonio Gonzalez Ortega

Senior Lead Industrial Project Management, Almirall

Petar Gyulev

Lifecycle Leader Hematology, Roche Pharmaceuticals

Xavier Mouric

Sales Executive, Planisware

Karin Merck

Senior Project Manager Cycletime Reduction in Mammalian Facility at Lonza

Jill Maria Thompson

Lifecycle Leader, Satralizumab, Roche Pharmaceuticals

Stephen Cho

Senior VP & Head Portfolio Strategy & Analytics, Novartis

Erik Adams

Global Director, Program and Project Management, CAI

Marc Neckermann

Consulting, ProSymmetry

Theresa Heil

Sales Consultant, Planisware

Show More Speakers

From our previous events

Testimonials

A great event with many open-minded (non-competing) participants that are willing to share their thoughts openly on many different, highly relevant topics.

Enjoyed many of the virtual presentations. Information was well organized, thorough, and to the topic.

Great relevant content and great speakers - very knowledgeable presenters with great presentation formats.

“I particularly enjoyed a variety of interesting topics on the agenda, knowledgeable speakers, participants and a great opportunity for networking”

“The topics were well chosen and the presentations well prepared. The opportunity to exchange thoughts and ideas with the participants was great!”

An event where everyone could participate in the conversation. Great mix of Panel discussion, round table and presentations that give the ability to network and meet everyone in the room.

AGENDA

VIEW ALL SESSIONS & THEIR DESCRIPTIONS

REGISTRATION

€ 2399

Access to All 23rd European Pharma and Biotech Project, Program and Portfolio Management Conference
Access to Post Conferences Networking
Conference Materials
Includes Coffee Breaks, Snacks and Refreshments, Seated Lunch

Present on the Main Stage
Hold an exhibit at this event
Showcase your Brand in Marketing Material
Gain exposure through alternative partnership benefits

event partners

CAI fundamentally exists for one reason: To be the trusted solution for our clients as they strive to build a better working world and improve the human experience. We are 800+ global experts that bring top-tier expertise to every stage of a project, from creating comprehensive, detailed project plans to eliminating that last punch list item and beyond, into rigorous asset management, reliability, and sustainability activities. We are your choice regardless of your location.

Gartner Research publishes a very popular research article entitled “Resource Management for Project Portfolio Management: Walk Before You Run.” As its name implies, the research article focuses on the various levels of project resource management maturity and the associated challenges and benefits faced along the way. Tempus Resource is a solution that takes specific aim at solving the resource management challenges faced by organizations of all types, shapes and sizes. We replace spreadsheets and can connect if needed to the leading PPM tools.

Established in 1999, Cora Systems have developed highly intelligent web – based enterprise platform which allows the end user to manage and control their programmes and projects from a single platform. Cora Systems provides an online application that gives you complete control, visibility and real time reporting across every single aspect and every single detail of every single programme and project.

Planview has one mission: to build the future of connected work. Our solutions enable organizations to connect the business from ideas to impact, empowering companies to accelerate the achievement of what matters most. Planview’s full spectrum of Portfolio Management and Work Management solutions create an organizational focus on the strategic outcomes that matter and empower teams to deliver their best work, no matter how they work. The comprehensive Planview platform and enterprise success model enables customers to deliver innovative, competitive products, services, and customer experiences. Headquartered in Austin, Texas, with locations around the world, Planview has more than 1,000 employees supporting 4,000 customers and 2.4 million users worldwide. For more information, visit www.planview.com.

Planisware is a global provider of software solutions for project portfolio management. Planisware solutions are specifically designed to support product development, engineering and IT business processes. For more than 20 years, Planisware has been helping its customers to achieve strategic and innovative excellence, make valid business decisions and increase portfolio value. Today, over 500 companies worldwide rely on Planisware products to manage their projects, resources and portfolios.

Founded in Gothenburg, Sweden, Captario is a fast-growing software company catering to the pharmaceutical industry. Captario develops SUM® – Strategic Uncertainty Management, a cloud-based modeling & simulation software further empowered by AI and Machine Learning. It enables project and portfolio teams to base strategic decisions on a rich understanding of practically all possible futures. A team can compare options and gain new insights regarding trade-offs between time, cost, risk and value. The approach has consistently led drug project and portfolio teams to substantially increase the overall value. Captario SUM sets a new gold standard for strategic decision making in drug development. Ultimately, this leads to better and more affordable medicines to patients in need.